WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 563977
CAS#: 1380411-57-3 (BF4)
Description: FC11409B is a CAIX inhibitor, inhibiting breast cancer invasion and metastasis.
MedKoo Cat#: 563977
Name: FC11409B
CAS#: 1380411-57-3 (BF4)
Chemical Formula: C29H23BF4N2O3S
Exact Mass: 566.1459
Molecular Weight: 566.38
Elemental Analysis: C, 61.50; H, 4.09; B, 1.91; F, 13.42; N, 4.95; O, 8.47; S, 5.66
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 1380411-57-3 (BF4) 1380411-56-2 (free base)
Synonym: FC11409B; FC-11409B; FC 11409B
IUPAC/Chemical Name: 2,4,6-Triphenyl-1-(4-(sulfamoyloxy)phenyl)pyridin-1-ium tetrafluoroborate
InChi Key: ODRMDUOSDISTHM-UHFFFAOYSA-N
InChi Code: InChI=1S/C29H23N2O3S.BF4/c30-35(32,33)34-27-18-16-26(17-19-27)31-28(23-12-6-2-7-13-23)20-25(22-10-4-1-5-11-22)21-29(31)24-14-8-3-9-15-24;2-1(3,4)5/h1-21H,(H2,30,32,33);/q+1;-1
SMILES Code: O=S(OC1=CC=C([N+]2=C(C3=CC=CC=C3)C=C(C4=CC=CC=C4)C=C2C5=CC=CC=C5)C=C1)(N)=O.F[B-](F)(F)F
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
The following data is based on the product molecular weight 566.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: Ward C, Meehan J, Mullen P, Supuran C, Dixon JM, Thomas JS, Winum JY, Lambin P, Dubois L, Pavathaneni NK, Jarman EJ, Renshaw L, Um IH, Kay C, Harrison DJ, Kunkler IH, Langdon SP. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models. Oncotarget. 2015 Sep 22;6(28):24856-70. doi: 10.18632/oncotarget.4498. PubMed PMID: 26259239; PubMed Central PMCID: PMC4694798.
